Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

Clinical trial NCT04017221 · COMPLETED

Trial details

NCT number: NCT04017221
Sponsor: Canadian Network for Observational Drug Effect Studies, CNODES
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2 Urosepsis Diabetic Ketoacidosis Lower Extremity Amputation

Start date: 2018-10-01
Primary completion: 2019-12-01
Enrollment: 1249636

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.